1. Home
  2. NAGE vs DSU Comparison

NAGE vs DSU Comparison

Compare NAGE & DSU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Niagen Bioscience Inc.

NAGE

Niagen Bioscience Inc.

HOLD

Current Price

$4.74

Market Cap

350.8M

Sector

Health Care

ML Signal

HOLD

Logo Blackrock Debt Strategies Fund Inc.

DSU

Blackrock Debt Strategies Fund Inc.

HOLD

Current Price

$9.82

Market Cap

607.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAGE
DSU
Founded
1999
N/A
Country
United States
United States
Employees
117
N/A
Industry
Medicinal Chemicals and Botanical Products
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
350.8M
607.9M
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
NAGE
DSU
Price
$4.74
$9.82
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
$16.00
N/A
AVG Volume (30 Days)
769.8K
256.4K
Earning Date
05-06-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.51
N/A
Revenue Next Year
$14.58
N/A
P/E Ratio
$21.29
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.16
$9.31
52 Week High
$14.66
$10.66

Technical Indicators

Market Signals
Indicator
NAGE
DSU
Relative Strength Index (RSI) 52.30 53.71
Support Level $4.39 $9.60
Resistance Level $5.32 $9.94
Average True Range (ATR) 0.16 0.11
MACD 0.06 0.04
Stochastic Oscillator 80.85 81.45

Price Performance

Historical Comparison
NAGE
DSU

About NAGE Niagen Bioscience Inc.

Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

About DSU Blackrock Debt Strategies Fund Inc.

Blackrock Debt Strategies Fund Inc is a closed-end management investment company. Its primary investment objective is to seek to provide current income by investing in a diversified portfolio of U.S. companies debt instruments, including senior and subordinated corporate loans, both secured and unsecured, which are rated in the lower rating categories of the established rating services or unrated debt instruments, which are in the judgment of the investment adviser of equivalent quality. The Fund may invest directly in debt instruments or synthetically through the use of derivatives. The Fund's secondary investment objective is to seek to provide capital appreciation.

Share on Social Networks: